Also, the usefulness of the serum HMGB1 as a potential biomarker was evaluated and the cut-off value of serum HMGB1 level was 4.80 ng/ml, the sensitivity and specificity in cancer identification were respectively 42.3% and 92.0%. The gene discussed is HMGB1; the disease is cancer.